2023

October
Highlighted Articles
- Significant and Sustained Reductions in Health Insurance Premiums Follow Medical Cannabis Legalization
  
  October 18, 2023
  States that have legalized cannabis for medical use report significant reductions in private health insurance premiums according to a recent study published in the Journal of International Drug Policy.
  Read More
September
Highlighted Articles
- New Longitudinal Study Finds Lack of Association Between Clinical Psychosis and Cannabis Use in High-Risk Young Adults and Adolescents
  
  September 20, 2023
  Neither continuous nor occasional cannabis use has been found to be linked to an increased transition rate towards psychosis or worsened clinical symptoms, functioning levels, or overall neurocognition, according to the study authors of a new longitudinal study.
  Read More
August
Highlighted Articles
- Rescheduling Cannabis to Schedule III Recommended by US Department of Health and Human Services
  
  August 31, 2023
  The rescheduling of cannabis from Schedule I to Schedule III has been advocated by the US Department of Health and Human Services (HHS) to the Drug Enforcement Agency (DEA), according to a memo obtained by Bloomberg.
  
  Read More
July
Highlighted Articles
- Unregulated Delta-8 THC Products Face New Scrutiny in New Jersey and from the FDA and FTC
  
  July 6, 2023
  There is growing concern over hemp-derived THC and CBD products that can be commonly bought at gas stations, convenience stores, and smoke shops.
  Read More
June
Highlighted Articles
- New Study Finds That Cannabis Legalization for Adult-Use May Cause Tobacco-Related Health Benefits
  
  June 15, 2023
  
  A study that is scheduled to be published in the July 2023 issue of the Journal of Health Economics found that cannabis legalization is associated with a lagged reduction in adult tobacco use that includes cigarettes, cigars, pipe tobacco, and e-cigarettes.
  
  Read More
May
Highlighted Articles
- Pennsylvania Court Rules that Employers Must Reimburse Out-of-Pocket Costs for Medical Cannabis in Workers Compensation Case
  
  May 10, 2023
  A Pennsylvania Court recently ruled that the mandate from the Workers’ Compensation Act that employers must reimburse workers for reasonable and necessary out-of-pocket costs of treatment from a workplace injury includes costs associated with the use of medical cannabis according to a ruling by the Commonwealth Court of Pennsylvania in the case of Fegley v. Firestone Tire & Rubber.
  
  Read More
April
Highlighted Articles
- Drexel MCRC Assistant Director Jim Seaberg Participates in 4/20 Panel on WURD Radio - More Than Green: The Color of Cannabis on WURD Radio
  
  April 24, 2023
  4/20, the unofficial day to celebrate cannabis, WURD held a frank and in-depth conversation about cannabis hosted by Brother Shomari entitled “More than Green: The Color of Cannabis.”
  Read More
- Anxiety and Cannabis: A Review of Recent Research
  
  April 10, 2023
  Anxiety disorders have become one of the top conditions for receiving medical cannabis since becoming a qualifying condition for the Pennsylvania Medical Marijuana (PAMMJ) Program in 2019. Yet, the application of cannabis as a treatment for anxiety disorders has been a controversial issue in Pennsylvania. While the media coverage surrounding this has been largely negative, it is important to understand the broader context of why so many people are seeking out cannabis for their anxiety – and reporting that it does help.
  Read More
March
Highlighted Articles
- Department of Justice Announces Applications for Cannabis Pardon Certificates
  
  March 9, 2023
  Persons pardoned for federal possession of cannabis – first announced in October, 2022 by President Joe Biden – can now receive a certificate demonstrating lawful receipt of the pardon via an application form launched by the Department of Justice on March 3^rd, 2023.
  Read More
February
Highlighted Articles
- State-level Cannabis Legalization Not Associated with Increase in Psychosis-Related Healthcare Utilization
  
  February 9, 2023
  A recent cohort study found no increase in psychosis-related diagnoses or prescribed antipsychotics in states that have legalized cannabis for medical or adult-use compared to those that continue to uphold cannabis prohibition.
  Read More
January
Highlighted Articles
- Pennsylvania Medical Marijuana Program Data Brief Released by Drexel-led State Epidemiological Outcomes Workgroup
  
  January 9, 2023
  The impact of the Pennsylvania Medical Marijuana program as it relates to access, use, arrests, and perceptions of cannabis was detailed in data brief released on January 2023 by the Drexel-led State Epidemiological Outcomes Workgroup.
  Read More